Kabir A Khan
7PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 14, 2025
Immunological Tolerance to Luciferase and Fluorescent Proteins Using Tol Mice Enables Development of Improved Tumor Models for Investigating Immunity and Metastasis.Kabir A Khan, Areeba A Qureshi, Ping Xu
|Apr 10, 2024
Antiangiogenic-immune-checkpoint inhibitor combinations: lessons from phase III clinical trials.Hung-Yang Kuo, Kabir A Khan, Robert S Kerbel
|Jan 14, 2022
Tumors resurrect an embryonic vascular program to escape immunity.Elisabeth J M Huijbers, Kabir A Khan, Robert S Kerbel
|Jun 14, 2021
Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer.Kabir A Khan, Florence Th Wu, William Cruz-Munoz
|Jul 25, 2020
Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer.Kabir A Khan, José L Ponce de Léon, Madeleine Benguigui
|May 15, 2020
A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis.Kabir A Khan, Robert S Kerbel
Pageof 2
Frequent Collaborators
4 joint publications
Robert S Kerbel
2 joint publications
Hung-Yang Kuo
1 joint publications
José L Ponce de Léon
1 joint publications
Florence Th Wu
1 joint publications
Elisabeth J M Huijbers
1 joint publications
Arjan W Griffioen
1 joint publications
Areeba A Qureshi
1 joint publications
Ping Xu
1 joint publications
Ton N Schumacher
1 joint publications
Iacovos P Michael
